Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2023 Apr 15:16:1267-1284.
doi: 10.2147/JPR.S404713. eCollection 2023.

Pain Fluctuations of Women with Subacute Herpetic Neuralgia During Local Methylcobalamin in Combination with Lidocaine Treatment: A Single-Blinded Randomized Controlled Trial

Gang Xu  1 , Weizhen Tang  1 , Chaosheng Zhou  1 , Jie Xu  1 , Chao Cheng  1 , Weiwei Gong  2   3 , Shihong Dong  2 , Yu Zhang  1
Affiliations
Clinical Trial

Pain Fluctuations of Women with Subacute Herpetic Neuralgia During Local Methylcobalamin in Combination with Lidocaine Treatment: A Single-Blinded Randomized Controlled Trial

Gang Xu et al. J Pain Res. .

Abstract

Purpose: To evaluate the efficacy and pain fluctuations of methylcobalamin in combination with lidocaine local injection treatment for subacute herpetic neuralgia (SHN).

Methods: Seventy-nine women (60.4 ± 2.7 years) with thoracic SHN were enrolled and randomized to receive a combination of methylcobalamin and lidocaine local injection (MI, N=40), or a combination of lidocaine patch 5% and oral methylcobalamin (PO, N=39) for four weeks. Repeated-measures analyses of variance were used to evaluate the effect on pain levels. Generalized estimation equations were used to analyze the cause-effect relationship between pain fluctuations and influencing factors.

Results: At the treatment endpoint, the group, treatment time, and group interacted with treatment time effects of the pain scores and area were statistically significant (P<0.001), The pain scores were 2.9 ±0.9 (MI) and 4.3 ± 1.5 (PO). 80.00% (MI) or 28.21% (PO) of patients had pain scores ≤ 3, the odds ratio was 2.84 (95% CI: 1.68 to 4.79). The incidence of postherpetic neuralgia was 5.0% (2/40) at 3 months. Pain fluctuated repeatedly during treatment. The pain fluctuation increased from 8.75 log folds in the afternoon, to 79.85 log folds at night. With the ADLs level increasing from 1 to 3, the pain fluctuated from 4.28 to 17.70 log folds. Allodynia, itching, sleep quality, and ADLs were the significant influencing factors (P<0.05).

Conclusion: This study validated the efficacy of methylcobalamin combined with lidocaine for SHN, and confirmed that pain levels in patients with SHN had an obvious circadian rhythm. ADLs were an important cause of pain fluctuations.

Keywords: activities of daily living; lidocaine; methylcobalamin; pain fluctuation; subacute herpetic neuralgia.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest concerning this article’s research, authorship, and/or publication.

Figures

Figure 1
Figure 1
Consort flow chart.
Figure 2
Figure 2
Mean pain score of subjects at each time point and ANOVA for repeated measures. MI group: the combination of methylcobalamin and lidocaine local injection. PO group: the combination of lidocaine patch and oral methylcobalamin. *p <0.05.
Figure 3
Figure 3
Mean pain area of subjects at each time point and ANOVA for repeated measures. MI group: the combination of methylcobalamin and lidocaine local injection. PO group: the combination of lidocaine patch and oral methylcobalamin. *p <0.05.
Figure 4
Figure 4
Comparisons of activities of daily living and quality of life scores in Zoster Brief Pain Inventory (ZBPI) before and after treatment. MI group: the combination of methylcobalamin and lidocaine local injection. PO group: the combination of lidocaine patch and oral methylcobalamin. *Compared with before treatment, P < 0.05. #Compared with control group, P < 0.05.
See this image and copyright information in PMC

References

    1. Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: a prospective study with long term follows up. BMJ. 2000;321:794–796. doi:10.1136/bmj.321.7264.794 - DOI - PMC - PubMed
    1. Werner RN, Nikkels AF, Marinovic B, et al. European consensus-based (S2k) guideline on the management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), part 2: treatment. J Eur Acad Dermatol Venereol. 2017;31:20–29. doi:10.1111/jdv.13957 - DOI - PubMed
    1. Kramer S, Baeumler P, Geber C, et al. Somatosensory profiles in acute herpes zoster and predictors of postherpetic neuralgia. Pain. 2019;160:882–894. doi:10.1097/j.pain.0000000000001467 - DOI - PubMed
    1. Bumgarner JR, Walker WH 2nd, Nelson RJ. Circadian rhythms and pain. Neurosci Biobehav Rev. 2021;129:296–306. doi:10.1016/j.neubiorev.2021.08.004 - DOI - PMC - PubMed
    1. Warfield AE, Prather JF, Todd WD. Systems and circuits linking chronic pain and circadian rhythms. Front Neurosci. 2021;15:705173. doi:10.3389/fnins.2021.705173 - DOI - PMC - PubMed